- Mylan Labs to acquire King Pharmaceuticals; deal cancelled
- Mylan Laboratories acquires Penederm in all-stock transaction
- King Pharmaceuticals acquires rights to three HMR drugs
- AHP's Wyeth-Ayerst in co-promotion with King
- King buys Jones in $3.2bn stock transaction
- King Pharmaceuticals acquires Meridian Medical
- King Pharmaceuticals sells 16mm shares in FOPO
- King buys Elan's primary care pharma unit
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.